electroCore Presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference

ROCKAWAY, NJ, Sept. 30, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference has been rescheduled to today, September 30, 2021 at 12:40 PM eastern time.

Details for the company’s presentation are as follows:


Cantor Fitzgerald Virtual Global Healthcare Conference:


Date: Thursday, September 30, 2021


Rescheduled Time: 12:40 pm EDT


Investors can register for the conference


HERE.

Following the conference a webcast replay of the presentation will be available on the Investor section of the company’s website,


www.electrocore.com


.


About electroCore, Inc.


electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.

For more information, visit


www.electrocore.com


.


Investors:
Rich Cockrell
CG Capital
404-736-3838
[email protected]

or

Media Contact:
Jackie Dorsky
electroCore
908-313-6331
[email protected]


Primary Logo